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such as epilepsy and auditory damage with hearing 
loss are evident in approximately 2 5％ of all pa-
tients 8,9）, even at present, after the advancement of 
treatment via antibiotics. Furthermore, in recent years, 
with the increase in the use of antibiotics in children, 
Hib has rapidly become drug resistant b-lactamase 
negative ampicilin resistance （BLNAR）, and Hib infec-
tions associated with meningitis, septicemia, acute epi-
glottitis, etc., tend to be increasingly intractable10,11）.
On such the situation, in 1998, the World Health Or-
ganization （WHO） released a statement to promote 
????????????
Bacterial meningitis caused by infantile Haemophilus 
influenza type b （Hib） is a bacterial infectious disease 
with a poor prognosis wherein death occurs in about 
over 5％ of all patients1〜7） and lingering after effects 
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???????
It becomes difficult to treat the onset of childhood Haemophilus influenza type b （Hib） meningitis due to 
the appearance of b-lactamase negative ampicilin resistance （BLNAR）. We investigated the clinical features 
of Hib meningitis with subdural lesions. From January 2000 to December 2006, we experienced 8 patients 
with Hib meningitis. All patients were not inoculated with Hib vaccine. Five of them were onset under 1 
year old. Rapid latex diagnoses were made in 5 patients, among whom 4 patients showed Hib positive. The 
genotypes were determined in 4 patients with BLNAR. Combined with cefotaxime sodium （CTX） and am-
picillin （ABPC） were used in 3 patients for the initial antibiotics, panipenem/betamipron （PAPM/BP） in 2, 
meropenem hydrate （MEPM） in 1, MEPM ＋ ceftriaxone sodium （CTRX） in 1, and concomitant use of dex-
amethasone in 7 paitents. MRI showed subdural hygroma in 4 patients and subdural abscess in 4 patients. 
Subdural lesions appeared on Day 1 to Day 18 from the onset. Three patients with subdural abscess have 
performed subdural taps, and 2of them with difficulties after subdural taps were necessary to do oral admin-
istration of chloramphenicol （CP）.
In our report, all of the patients developed subdural lesions. The development of subdural lesions cannot 
be avoided with only the conventional antibiotics and dexamethasone therapy. Our cases suggested earlier 
subdural taps with oral administration of CP might be to improve both the general condition and control the 
subdural lesions with Hib meningitis. Moreover, we should pay attention to the preventive vaccination of 
Hib.
???? ????： Haemophilus Influenzae, subdural hygroma, subdural hematoma, vaccine, magnetic reso-
nance imaging, single photon emission computed tomography
?????????
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1.  Gender, age, time of onset, presence or absence of 
underlying disease
The gender and age of onset of the 8 patients were 
6 for boys and 2 for girls. The distribution of the age 
of onset was determined as 1 month after birth at the 
youngest and 7 years 0 months after birth at the old-
est, and the median was 20 months. Of these, 5 pa-
tients were infants who were under 1 year old. The 
months of development were March and June in 7 pa-
tients. As for the presence or absence of a background 
underlying disease, a 7 year and 0 month old girl had 
cerebral palsy compounded by trouble with a ventricu-
loperitoneal shunt. One patient was a newborn baby, 
but this does not apply as an underlying disease.
2.  Rapid diagnosis by latex agglutination reaction with 
Hib
Rapid diagnoses by latex agglutination reaction us-
ing a rapid kit （Fig. 1） were made in 5 of 8 patients. 
Two of the patients showed no agglutination, so a rap-
id diagnosis could not be determined. The general cul-
tivation of bacteria in the spinal fluids revealed Hib in 
all of the patients.
3.  analyze the genotypes1,2） 
We requested the Graduate School of Infection Con-
trol Sciences, Kitasato Institute for Life Sciences, to an-
alyze the genotypes only in 5 patients. The results 
showed BLNAR with the variation of the PBP-3 gene 
in 4 patients.
4. Treatment
The use of antibiotics was immediately initiated in 
all of the patients. The types of initial antibiotics that 
were used included ABPC＋CTX in 3 patients and 
CZOP＋AMK in 1 patient, PAPM/BP in 2 patient, 
MEPM in 1 patient and MEPM＋CTRX in 1 patient. 
The dosages of the antibiotics that were used consist-
ed of 2 increments of 120 mg/kg/day of MEPM, 3 in-
crements of 200 mg/kg/day of CTX, 2 increments of 
200 mg/kg/day of ABPC, 2 increments of 100 mg/kg/
day of PAPM/BP, 1 increment of 100 mg/kg/day of 
CZOP and 8 mg/kg/day of AMK, respectively.
In 7 of 8 patients, dexamethasone was used before 
each administration of the antibiotics with a dosage of 
4 increments of 0.6 mg/kg/day. The period of adminis-
regular vaccination with a Hib vaccine in infants, and 
regular vaccinations were subsequently introduced in 
more than 100 countries, including developing coun-
tries throughout the world12〜16）. By the enforcement of 
the regular vaccination of Hib on the international 
scale by WHO, the frequency of meningitis due to Hib 
has rapidly decreased, so it is believed that it is a rare 
disease on a global scale.
On the other hand, no Hib vaccine had yet been ap-
proved in Japan11）. Therefore meningitis by Hib still 
developed in more than 600 patients annually in Japan. 
In January 2007, Hib vaccine was finally approved by 
the Ministry of Health, Labour and Welfare and has 
been become available for not only regular but also 
voluntary vaccination17）.
Based on these social circumstances, we summarized 
the clinical presentations of Hib meningitis including 
BLNAR that we observed at our hospital, and we in-
sist on the necessity to introduce a regular vaccination 
of the Hib vaccine in Japan in this article.
????????????????????
The subjects consisted of 8 patients with acute pu-
rulent meningitis caused by Hib who were hospitalized 
at Dokkyo Medical University Hospital during the 
7-year period from January 2000 to December 2006. 
Acute purulent meningitis was clinically diagnosed 
based on the increase in the number of spinal fluid 
cells and the results of bacterial cultivation of the spi-
nal fluids. The following five factors were retrospec-
tively studied in each subject based on our hospital’s 
medical records：1. gender, age of onset, time of onset, 
the presence or absence of underlying diseases；2. dif-
ferences between the results of the rapid diagnoses by 
latex agglutination reaction （Applied Bio-Rad Ltd, PA-
STOREX Ⓡ . MENINGITIS, France） and the general 
cultivation of bacteria；3. analysis the Hib genotypes, 
the variation of the penicillin-binding protein （PBP） 
gene1,2）；4. antibiotics used；and 5 . the presence or 
absence of subdural lesions with others.
???????
The results of summarizing the clinical courses of all 
8 subjects are shown in （Table 1）.
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formed with subdural taps and 2 increments of 100 
mg/kg/day of CP were orally administered as part of 
antibiotics treatment, after which the amelioration of 
the subdural abscess was observed with the passage 
of time.
In the 4 patients in whom subdural hygroma was 
observed, the continued administration of the already 
administered antibiotics ameliorated the hygroma.
As for neurological prognoses, concomitant symp-
toms that were observed within the observation period 
until September 2010 included epileptic seizure in 4 
patients, auditory disorder in 0 , and death in 0 pa-
tients.
??????????
We studied 8 patients with Hib meningitis in child-
hood. We made early diagnoses of Hib using spinal flu-
id via the latex method and treated with appropriate 
antibiotics according to sensitivity, but all of the pa-
tients developed subdural lesions. Our cases indicate 
that it is impossible to avoid the complication of devel-
oping subdural lesions with the administration of the 
currently available antibiotics alone with Hib meningi-
tration of dexamethasone was 2 patients in 3 days and 
5 patients in 4 days.
The other concomitantly used drugs included man-
nitol, and midazolam that was continuously adminis-
tered in subjects in whom convulsive symptoms were 
observed.
5. Subdural lesions and neurological prognoses
Several brain CT or MRI examinations were per-
formed at appropriate times in all of the patients, and 
the complication of the development of subdural le-
sions was neuro-radiologically studied. The results 
showed the compounded development of subdural le-
sions in all of 8 patients. The details consisted of sub-
dural abscess in 4 patients and subdural hygroma in 4 
patients. The time of onset of subdural hygroma or ab-
scess was 1 to 18 days after the initiation of treatment, 
which was diagnosed via neuro-radiological imaging 
（Fig. 2）.
Four patients with subdural abscess were initially 
treated with antibiotics that improved general condi-
tions but failed to reduce the abscesses in size. Three 
out of 4 patients with hematoma, drainage was per-
176 DJMS
????????　 Latex agglutination reaction using a rapid kit showed agglutination reaction to 
Hi in patient No.5. （1/A：control with Haemophilus influenza type b, 2/B：
Streptococcus pneumoniae, 3/C：Escherichia coli, 4/D：Neisseria meningitides, 
5/F：group B streptococci, 6/G：Haemophilus influenza type b） 
Haemophilus influenzae meningitis associated with subdural lesions
pan, Hasegawa et al. reported in 2004 that 21 .3％ of 
the Hemophilus influenzae that was investigated in 
2002 showed BLNAR, which is a problem, because the 
detection rate is very high11,17）. After we diagnosed 
Hib according to the latex rapid reaction, we suspected 
BLNAR and selected antibiotics such as MEPM and 
PAPM/BP as well as the fourth- or third-generation 
cephalosporins such as CZOP and CTX. Dexametha-
sone therapy was reported21〜23） and was determined 
as effective in preventing auditory damage8,9）. Howev-
er, we could not avoid the complications of subdural le-
sions in all 8 patients.
It has been reported that the complication of sub-
dural lesions is often observed in Hib meningitis24,25）, 
and methods of treating it often become problematic 
during the course of Hib meningitis. All of our Hib 
meningitis exhibited subdural lesions. Anzai et al. re-
ported 9 cases of Hib meningitis with subdural abscess 
and performed subdural taps in 4 patients, and they 
concluded earlier intervention with subdural taps to 
the subdural abscess might be prevented additional 
complications 26）. According to our patients No.4 , 5 , 8 
with only subdural hygroma showed amelioration 
tis.
Regarding the diagnosis of Hib meningitis, it is nec-
essary to be performed in spinal fluid to detect the 
causative bacterium, and appropriate treatment was 
given accordingly. Meanwhile, until the causative bac-
terium was determined, treatment with an antibiotic 
was administered after the causative bacterium with 
empiric therapy. We performed latex agglutination us-
ing spinal fluid to make an earlier diagnoses of Hib and 
initiated treatment with antibiotics. This kit was very 
useful, because very early diagnoses of causative bac-
teria that induced the bacterial infectious diseases 
could be made within about 15 minutes, and differen-
tial diagnoses of pneumococcal organisms, Escherichia 
coli, meningococcus, etc., could also be simultaneously 
made in addition to Hib18〜20）. For antimicrobial thera-
py, the ampicillin, is generally regarded as effective, 
but in recent years, ampicillin-resistant Hib has be-
come a problem. In our patients, BLNAR was also ob-
served in 4 patients. BLNAR was first reported in 
1980 due to the increased use of treatment with sever-
al antibiotics. PBP-3 of penicillin-binding protein is in-
volved in the mechanism of acquiring resistance. In Ja-
??（3） （2010） 177
????????　 Brain MRI FLAIR images （spin echo：TR＝9,000 msec/TE＝105 msec） with contrast agent 
（A/B：patient No.7, E/F：patient No.6） （C/D：patient No.7, G/H：patient No.6） revealed 
enhancement image of miginx and severe subdural effusion in patients with Hib meningitis. 
99mTc-ECD SPECT （C/D：patient No.7, G/H：patient No.6） exhibited hypoperfusion cortical 
areas consisted with adjacent to the subdural effusion.
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development of Hib meningitis and Hib infections. At 
present, it is speculated that 8 . 6 to 8 . 9 people per 
100,000 people who are below the age of 5 years old 
are affected with bacterial meningitis per year in Ja-
pan15）. Vaccination of the Hib is recommended for 
younger children under 5 years old, but we treated 
Hib meningitis in a 7-year-old in patient No.2. The Ja-
pan Pediatric Society submitted a requisition paper to 
the Ministry of Health, Labour and Welfare in June 
2005, requesting early approval. At the end of January 
2007, the production of an Hib vaccine （ActHIB®） was 
finally approved17）. In the United States, regular vacci-
nation with Hib vaccines was introduced in 1987, thus 
resulting in a dramatic decrease to 1/100 of the infec-
tions caused by Hib3,7）. In the UK, vaccines were ap-
proved in 1992, and the prevalence of Hib in patients 
under 5 years old decreased to 0.6 per 100,000 people 
in 19983,4）. With the approval of Hib vaccine in Japan 
as a turning point, it is expected that Hib meningitis in 
Japan will dramatically decrease in the near future. 
However, Hib vaccination is currently voluntary. It is 
preferable for Hib vaccination to be incorporated into 
regular vaccinations as a government policy. To pre-
vent the Hib meningitis associated with subdural le-
sions, attention should be paid to the promotion of pre-
ventive vaccinations of Hib vaccine.
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